Frank G. Haluska MD

Breast Cancer, Hematologic Oncology

Physician

750 Washington StNemc Box #836Boston, MA 02111
Phone+1 617-636-5000

Dr. Haluska is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haluska's full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1995
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1989 - 1991
Perelman School of Medicine at the University of PennsylvaniaClass of 1989

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1991 - 2027

Publications & Presentations

PubMed

19 citations
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers.
Suzanne George, Margaret von Mehren, Jonathan A Fletcher, Jichao Sun, Sen Zhang
Clinical Cancer Research. 2022-04-01
469 citations
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
Jorge E. Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp le Coutre, Ronald Paquette
Blood. 2018-07-26
435 citations
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong Wan Kim, Marcello Tiseo, Myung-Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen
Journal of Clinical Oncology. 2017-05-05

Press Mentions

Anchiano Appoints Steve DiPalma as Chief Financial OfficerMay 5th, 2020
Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceSeptember 20th, 2019
Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceSeptember 3rd, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Stephen Louie, MD
OncBoston, MA
Vijay Kasturi, MD
OncBoston, MA
Raymond Comenzo, MD
OncBoston, MA
Virginia Zaleskas, MD
OncBoston, MA
Rachel Buchsbaum, MD
OncBoston, MA
Don Dizon, MD
OncBoston, MA
Elaine Choi, MD
OncBoston, MA
Lori Pai, MD
OncBoston, MA
David Schenkein, MD
OncBoston, MA
Paul Mathew, MD
OncBoston, MA

Doximity / States / Massachusetts / Boston / Frank Haluska, MD

Dr. Frank Haluska, Dr. Frank Haluska, MD, Dr. F Haluska, Dr. Frank G. Haluska